United States · FDA National Drug Code directory
OSENI
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 64764-123_2346b7f5-b2c1-45f0-9f8f-5cbb4b202857
- Product NDC
- 64764-123
- Form
- TABLET, FILM COATED
- Composition / generic term
- alogliptin and pioglitazone
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20130125
- Source listing expiry
- 20261231
Source-listed ingredients
- ALOGLIPTIN BENZOATE — 12.5 mg/1
- PIOGLITAZONE HYDROCHLORIDE — 30 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (64764-123-03) · 64764-123-03
- 90 TABLET, FILM COATED in 1 BOTTLE (64764-123-04) · 64764-123-04
- 500 TABLET, FILM COATED in 1 BOTTLE (64764-123-05) · 64764-123-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →